Literature DB >> 18647820

Factors controlling testis descent.

Ieuan A Hughes1, Carlo L Acerini.   

Abstract

Descent of the testis from an intra-abdominal site in foetal life to an extracorporeal location after birth is a mandatory developmental process to ensure that the mature testis promotes normal spermatogenesis. The two phases of transabdominal and inguinoscrotal descent occur approximately during the first and last thirds of gestation respectively. Key anatomical events to release the testis from its urogenital ridge location and to guide the free gonad into the scrotum are the degeneration of the cranio-suspensory ligament and a thickening of the gubernaculum. Androgens play a role in both these processes, particularly with respect to enabling the testis to traverse the inguinal canal in the final phase of descent. Experiments in animals suggest that androgens mediate this effect via the release of calcitonin gene-related peptide by the genitofemoral nerve, but direct evidence for such a mechanism is lacking in humans. The transabdominal phase of descent is under the control of insulin-like 3 (INSL3), a product of the Leydig cells. Definitive evidence of its role in rodent testis descent is illustrated by the phenotype of bilateral cryptorchidism in Insl3-/- null mice. Circulating levels of INSL3 are higher in boys at puberty, are undetectable in girls and are lower in boys with undescended testes. A minority also have a mutation either in the INSL3 gene or affecting its receptor gene, relaxin/insulin-like family peptide receptor 2 (LGRF8). Other factors that may play a role in testis descent include the anti-Mullerian hormone and members of the HOX gene family. Evidence that the prevalence of undescended testis may be increasing provides a phenotypic readout for the effects of postulated chemicals in the environment interfering in some way with the action of factors that control testis descent. Epidemiological studies point to profound geographical variations in prevalence in countries such as Denmark and Finland. Associations have been found with levels of chemicals labelled as endocrine disruptors being higher in breast milk samples from mothers with cryptorchid boys when compared with controls. The adverse effects of these compounds (e.g. bisphenol A) can be replicated in the offspring of dams exposed during pregnancy. A sensitive marker of an anti-androgen effect of a compound is a reduction in the anogenital distance, an anthropometric measurement that is significantly greater in males compared with females. The observation of an association between the anogenital distance in infant boys and the level of pesticides in the urine of their mothers in late gestation indicates that this has the potential to be a useful surrogate marker of the effects of environmental chemicals on testis descent in human population studies. The rightful place for the testis at birth is in the scrotum in order to provide the temperature differential essential for normal spermatogenesis. Appropriate screening programmes and early surgical intervention are the prerequisites to ensure optimal fertility in adulthood and a considerably lessened risk of testis cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18647820     DOI: 10.1530/EJE-08-0458

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  38 in total

Review 1.  Cumulative effects of antiandrogenic chemical mixtures and their relevance to human health risk assessment.

Authors:  Kembra L Howdeshell; Andrew K Hotchkiss; L Earl Gray
Journal:  Int J Hyg Environ Health       Date:  2016-11-19       Impact factor: 5.840

Review 2.  Cumulative effects of in utero administration of mixtures of reproductive toxicants that disrupt common target tissues via diverse mechanisms of toxicity.

Authors:  C V Rider; J R Furr; V S Wilson; L E Gray
Journal:  Int J Androl       Date:  2010-04

3.  The male reproductive system in classic galactosemia: cryptorchidism and low semen volume.

Authors:  Cynthia S Gubbels; Corrine K Welt; John C M Dumoulin; Simon G F Robben; Catherine M Gordon; Gerard A J Dunselman; M Estela Rubio-Gozalbo; Gerard T Berry
Journal:  J Inherit Metab Dis       Date:  2012-10-11       Impact factor: 4.982

Review 4.  Analgesic use in pregnancy and male reproductive development.

Authors:  Pablo Hurtado-Gonzalez; Rod T Mitchell
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-06       Impact factor: 3.243

Review 5.  Risk factors for cryptorchidism.

Authors:  Jason K Gurney; Katherine A McGlynn; James Stanley; Tony Merriman; Virginia Signal; Caroline Shaw; Richard Edwards; Lorenzo Richiardi; John Hutson; Diana Sarfati
Journal:  Nat Rev Urol       Date:  2017-06-27       Impact factor: 14.432

6.  The role of RXFP2 in mediating androgen-induced inguinoscrotal testis descent in LH receptor knockout mice.

Authors:  F P Yuan; X Li; J Lin; C Schwabe; E E Büllesbach; C V Rao; Z M Lei
Journal:  Reproduction       Date:  2010-02-12       Impact factor: 3.906

7.  In utero exposure to an AR antagonist plus an inhibitor of fetal testosterone synthesis induces cumulative effects on F1 male rats.

Authors:  A K Hotchkiss; C V Rider; J Furr; K L Howdeshell; C R Blystone; V S Wilson; L E Gray
Journal:  Reprod Toxicol       Date:  2010-06-15       Impact factor: 3.143

Review 8.  Endocrine disruptors and Leydig cell function.

Authors:  K Svechnikov; G Izzo; L Landreh; J Weisser; O Söder
Journal:  J Biomed Biotechnol       Date:  2010-08-25

9.  The Second-to-Fourth Digit Ratio in Cryptorchidism: A Case-Control Study.

Authors:  Hawook Hwang; Hyun Wook Jo; Bongju Yun; Taewoo Kim; Daeseon Yu; Jinsung Park; Dae Kyeng Kim; Seung Hyo Woo
Journal:  Korean J Urol       Date:  2014-02-14

Review 10.  Male reprotoxicity and endocrine disruption.

Authors:  Sarah Campion; Natasha Catlin; Nicholas Heger; Elizabeth V McDonnell; Sara E Pacheco; Camelia Saffarini; Moses A Sandrof; Kim Boekelheide
Journal:  Exp Suppl       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.